• Publications
  • Influence
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
TLDR
The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
TLDR
This document represents the current state of knowledge regarding idiopathic pulmonary fibrosis, and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course.
Grading quality of evidence and strength of recommendations
TLDR
A system for grading the quality of evidence and the strength of recommendations that can be applied across a wide range of interventions and contexts is developed, and a summary of the approach from the perspective of a guideline user is presented.
GRADE guidelines: 3. Rating the quality of evidence.
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
TLDR
Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups.
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
TLDR
This document updates the American Thoracic Society/European Respiratory Society/Japanese Respiratories Society/Latin American ThorACic Association guideline on idiopathic pulmonary fibrosis treatment with new recommendations made for or against specific treatment interventions.
...
1
2
3
4
5
...